RALEIGH, NC and TELAVIV, ISRAEL / ACCESSWIRE / December 15, 2021 / RedHill Biopharma Ltd. NASDAQ:RDHL "RedHill" or the "Company", a specialty biopharmaceutical company, today announced that members of its board of directors and senior management, including the Companys Chairman & CEO, Mr. Dror BenAsher, collectively purchased approximately an additional 66,0... Lire le communiqué |